Body Detox
On sale on the US market (according to the DSLD)
BodyHealth, food supplement from the US market
Body Detox (BodyHealth), a food supplement au code-barres 793573856487, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- À vérifier
Fulvic acid is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
Source: Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), POL-NF-00369.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- BodyHealth
- Barcode
- 793573856487
- Form
- Liquid
- One serving
- « 1 Spray(s) »
- Servings
- up to 1 serving per day
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Blend | Blend | 0.125 mL |
| Oligopolysaccharides | TBD | not stated |
| Lactobacillus extract | Micro-organism | not stated |
| Bifidus extract | Micro-organism | not stated |
| Glycine | Amino acid | not stated |
| Acetyl-Cysteine | Other substance | not stated |
| Glycoproteins | Protein | not stated |
| Phospholipids | Fat | not stated |
| Colloidal Sea Minerals | Blend | not stated |
| microcluster structured Water | Other | not stated |
| microactivated Enzymes | Blend | not stated |
| microactivated mercury-free Chlorella | Other | not stated |
| Lipoic Acid | Other substance | not stated |
| Glutathione | Other substance | not stated |
| Vitamin C | Vitamin | not stated |
| Hyaluronic Acid | Other substance | not stated |
| Fulvic Acid | Other substance | not stated |
| Ferulic Acid | Other substance | not stated |
| Protease Inhibitors | Other substance | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Body Detox
Entered into DSLD on 23 July 2020. Withdrawn from the US market on 11 August 2021 (according to the DSLD).Same active composition.
Official label: Body Detox
Entered into DSLD on 24 March 2017. Withdrawn from the US market on 21 April 2020 (according to the DSLD).- Active ingredient added : Ingredients (quantity not stated)
- Active ingredient added : mercury-free Chlorella (quantity not stated)
- Active ingredient added : NAC (quantity not stated)
- Active ingredient removed : Acetyl-Cysteine (quantity not stated)
- Active ingredient removed : Bifidus extract (quantity not stated)
- Active ingredient removed : Glycine (quantity not stated)
- Active ingredient removed : Lactobacillus extract (quantity not stated)
- Active ingredient removed : microactivated mercury-free Chlorella (quantity not stated)
- Active ingredient removed : microcluster structured Water (quantity not stated)
- Active ingredient removed : Protease Inhibitors (quantity not stated)
- Different unit, without conversion : Proprietary Blend: quantity not stated in this version; 0.125 mL on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Lipoic Acid
Read the warning, when it applies and the studies cited
DL-ALPHA-LIPOIC ACID/R-ALPHA-LIPOIC ACID
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Jacob et al. 1999, Konrad et al. 1999, Packer et al. 1995).
Sources cited by Health Canada (3)
- Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radical Biology & Medicine 1999;27(3-4):309-314. PubMed Randomised trial
- Konrad T, Vicini P, Kusterer K, Höflich A, Assadkhani A, Böhles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel KH. Alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 1999;22(2):280-287. PubMed
- Packer L, Witt EH, Tritschler HJ. Alpha-Lipoic acid as a biological antioxidant. Free Radical Biology & Medicine 1995;19(2):227-250. PubMed Review article
Applies to products providing 42 milligrams or more DL-alpha-lipoic acid or 21 milligrams or more R-alpha-lipoic acid, per day.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience sweating, paleness, chills, headache, dizziness and/or confusion (as these may be symptoms of serious low blood sugar) (Bae et al., 2013; Gullo et al., 2014; Bresciani et al., 2011; Chang et al., 2009).
Sources cited by Health Canada (4)
- Bae SM, Bae MN, Kim EY, Kim IK, Seo MW, Shin JK, Cho SR, Jeong GH. Recurrent Insulin Autoimmune Syndrome Caused by α-Lipoic Acid in Type 2 Diabetes. Endocrinol Metab (Seoul). 2013;28(4):326-330. PubMed
- Bresciani E, Bussi A, Bazzigaluppi E, Balestrieri G. Insulin autoimmune syndrome induced by α-lipoic acid in a Caucasian woman: case report. Diabetes Care. 2011 Sep;34(9):e146. doi: 10.2337/dc11-0600. DOI
- Chang HJ, Choi HS, Park MY, Leem SM, Jang YS, Park KS, Lee JM. A case of insulin autoimmune syndrome related to alpha-lipoic acid. Korean J Med 2009;76:600-604.
- Gullo D, Evans JL, Sortino G, Ira D. Goldfine and Vigneri R. Insulin autoimmune syndrome (Hirata Disease) in European Caucasians taking a-lipoic acid. Clinical Endocrinology 2014;81: 204-209. PubMed
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : BodyHealth
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Body Detox (BodyHealth): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/793573856487-body-detox-bodyhealth, updated 22 January 2022.